IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
556.93
+11.07 (2.03%)
Aug 21, 2026, 4:00 PM EDT - Market closed
IDEXX Laboratories Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,553 | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 |
Revenue Growth | 12.77% | 10.42% | 6.46% | 8.72% | 4.73% | 18.80% |
Gross Profit Gross Profit Growth | 2,843 | 2,660 | 2,379 | 2,190 | 2,004 | 1,889 |
Operating Income Operating Income Growth | 1,468 | 1,360 | 1,190 | 1,097 | 898.77 | 932.03 |
Net Income Net Income Growth | 1,140 | 1,059 | 887.87 | 845.04 | 679.09 | 744.85 |
Earnings Per Share EPS Growth | 14.22 | 13.08 | 10.67 | 10.06 | 8.03 | 8.60 |
EPS Growth | 18.41% | 22.59% | 6.06% | 25.28% | -6.63% | 28.17% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
IDEXX VetLab Consumables IDEXX VetLab Consumables Growth | 1,620 | 1,497 | 1,303 | 1,188 | 1,057 | 1,007 |
Rapid Assay Products Rapid Assay Products Growth | 351.19 | 348.95 | 359.75 | 344.49 | 313.67 | 296.85 |
Reference Laboratory Diagnostic & Consulting Reference Laboratory Diagnostic & Consulting Growth | 1,505 | 1,424 | 1,336 | 1,279 | 1,178 | 1,124 |
CAG Diagnostics Services & Accessories CAG Diagnostics Services & Accessories Growth | 142.11 | 137.42 | 130.37 | 124.05 | 111.26 | 107.27 |
CAG Diagnostics Capital - Instruments CAG Diagnostics Capital - Instruments Growth | 199.24 | 200.21 | 131.93 | 137.6 | 147.33 | 149.14 |
Veterinary Software, Services & Diagnostics Veterinary Software, Services & Diagnostics Growth | 366.1 | 345.88 | 312.62 | 279.33 | 251.19 | 206.26 |
Water Segment Water Segment Growth | 213.66 | 201.15 | 185.11 | 168.15 | 155.72 | 146.51 |
LPD Segment LPD Segment Growth | 139.09 | 131.79 | 122.06 | 121.66 | 122.61 | 135.89 |
Other Other Growth | 17.18 | 17.48 | 16.29 | 18.79 | 30.2 | 43.01 |
Revenue (Total) Revenue (Total) Growth | 4,553 | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 196.93 | 180.07 | 288.27 | 453.93 | 112.55 | 144.45 |
Total Debt Total Debt Growth | 1,096 | 976.51 | 986.95 | 1,067 | 1,470 | 1,031 |
Net Cash (Debt) Net Cash Growth | -899.15 | -796.44 | -698.68 | -613.42 | -1,357 | -886.56 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.22 | -9.83 | -8.39 | -7.30 | -16.05 | -10.24 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,372 | 1,182 | 929 | 906.51 | 542.98 | 755.55 |
Capital Expenditures CapEx Growth | -117.18 | -124.68 | -120.92 | -133.63 | -148.84 | -119.55 |
Free Cash Flow Free Cash Flow Growth | 1,254 | 1,057 | 808.08 | 772.88 | 394.15 | 636 |
Free Cash Flow Growth | 59.92% | 30.82% | 4.55% | 96.09% | -38.03% | 17.54% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.45% | 61.80% | 61.04% | 59.82% | 59.52% | 58.76% |
Operating Margin | 32.23% | 31.60% | 30.53% | 29.97% | 26.69% | 28.99% |
Pretax Margin | 31.28% | 30.77% | 28.48% | 28.99% | 25.54% | 28.07% |
Profit Margin | 25.03% | 24.62% | 22.78% | 23.08% | 20.17% | 23.16% |
FCF Margin | 27.55% | 24.56% | 20.73% | 21.11% | 11.71% | 19.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 39.16 | 50.99 | 38.13 | 54.55 | 49.75 | 74.96 |
Forward PE | 35.55 | 48.03 | 35.35 | 51.93 | 44.25 | 73.77 |
P/FCF Ratio | 34.98 | 51.10 | 41.90 | 59.64 | 85.72 | 87.79 |
PS Ratio | 9.64 | 12.55 | 8.69 | 12.59 | 10.03 | 17.36 |